반응식
[C:1]1([CH3:17])[CH:6]=[CH:5][CH:4]=[C:3]([N:7]2[C:11]([NH2:12])=[CH:10][C:9]([C:13]([F:16])([F:15])[F:14])=[N:8]2)[CH:2]=1.Cl[C:19]([O:21][C:22]1[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=1)=[O:20]>>[C:1]1([CH3:17])[CH:6]=[CH:5][CH:4]=[C:3]([N:7]2[C:11]([NH:12][C:19](=[O:20])[O:21][C:22]3[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=3)=[CH:10][C:9]([C:13]([F:15])([F:14])[F:16])=[N:8]2)[CH:2]=1참가 물질
3
실험 절차
Following the procedure in Example 118A, 1-m-tolyl-3-(trifluoromethyl)-1H-pyrazol-5-amine (380 mg, 1.58 mmol) and phenyl chloroformate (0.60 mL, 4.74 mmol) were reacted to give phenyl 1-m-tolyl-3-(trifluoromethyl)-1H-pyrazol-5-ylcarbamate (330 mg, 0.91 mmol, 58%). 1H NMR (300 MHz, DMSO-d6) δ 10.4 (br s, 1H), 7.62-6.85 (m, 10H), 2.46 (s, 3H); LC-MS (ESI) m/z 362 (M+H)+.
후처리
- customwere reacted
출처 및 근거
- ORD 기록
- ord-eff5608bdd2a4a36ac25383d348a07f4
- 출처 데이터셋
- uspto-grants-2016_04
- 특허 번호
- US09320739B2
연결된 노트
불러오는 중…